SUSAN NELSON: Open Payments
NPI 1093332645 · WESTMINSTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$180 in 9 payments from 7 companies in 2025. Trend: 2023 $609 · 2024 $284 · 2025 $180
Food & beverage: $180
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $63 |
| Exact Sciences Corporation | 1 | $30 |
| Lilly USA, LLC | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Novo Nordisk Inc | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: VRAYLAR, Cologuard Collection Kit, UBRELVY, MOUNJARO, FARXIGA, Ozempic, TRINTELLIX, VOQUEZNA.
Industry payments across MD — which companies pay providers there.
